Obiettivo Adjuvants are critical to the quality and magnitude of immune responses generated by PRD vaccines. However, vaccine development is hampered by lack of access to appropriate adjuvants. This is partly because adjuvants are developed in many organizations, with individual models and protocols that have been established independently. The resulting data on adjuvants are only rarely directly comparable and exploitable in other vaccine studies. The project objective is to determine the laboratory tests that can be used to harmonize pre-clinical determination of vaccine adjuvant activity and safety throughout Europe, including new-member countries, and in the developing world, based on an in-depth survey and analysis of best practice employed by industry and other stakeholders in adjuvant R&D. A database of survey results will be analysed by experts and used to establish the tests that are considered most useful by stakeholders to characterize adjuvant activity and safety. Dissemination of results will occur through a workshop organized with WHO for stakeholders (including key international organizations representatives), publications and websites. The tests will allow the activities of adjuvants to be compared directly and will therefore contribute a major advantage in the selection of adjuvants to be included in PRD vaccine development programmes. Campo scientifico natural sciencescomputer and information sciencesdatabasesmedical and health sciencesbasic medicineimmunologymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines Parole chiave PRD vaccine adjuvants adjuvant testing platform dissemination survey best practice testing harmonization Programma(i) FP7-HEALTH - Specific Programme "Cooperation": Health Argomento(i) HEALTH-2007-2.3.2-11 - Support platform for the development of PRD vaccines Invito a presentare proposte FP7-HEALTH-2007-B Vedi altri progetti per questo bando Meccanismo di finanziamento CSA-SA - Support actions Coordinatore STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER Contributo UE € 90 000,00 Indirizzo LANGE KLEIWEG 161 2288 GJ Rijswijk Zh Paesi Bassi Mostra sulla mappa Regione West-Nederland Zuid-Holland Agglomeratie ’s-Gravenhage Tipo di attività Research Organisations Contatto amministrativo Alan William Thomas (Dr.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato Partecipanti (2) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto WORLD HEALTH ORGANIZATION Svizzera Contributo UE € 100 000,00 Indirizzo Avenue Appia 20 1211 Geneve Mostra sulla mappa Regione Schweiz/Suisse/Svizzera Région lémanique Genève Tipo di attività Research Organisations Contatto amministrativo Martin Friede (Dr.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato EUROPEAN VACCINE INITIATIVE EWIV Germania Contributo UE € 110 000,00 Indirizzo VOSSSTRASSE 2 GEB 4040 69115 Heidelberg Mostra sulla mappa Regione Baden-Württemberg Karlsruhe Heidelberg, Stadtkreis Tipo di attività Research Organisations Contatto amministrativo Odile Leroy (Dr.) Collegamenti Contatta l’organizzazione Opens in new window Sito web Opens in new window Costo totale Nessun dato
